Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Status:
Completed
Trial end date:
2016-08-17
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining chemotherapy with peripheral stem cell transplant may
allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells.
PURPOSE: This phase II trial is studying how well allogeneic stem cell transplant works in
treating patients with metastatic kidney cancer.